Capricorn Fund Managers’s Cytokinetics CYTK Stock Holding History

Capricorn Fund Managers’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.98M	Buy	+81,879	New	+$5.88M	0.55%	58

Other funds holding CYTK

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS)

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Capricorn Fund Managers's CYTK Position: Q2 2026 in Review

Capricorn Fund Managers opened a new position in Cytokinetics (CYTK) in Q2 2026: 81,879 shares worth $6.98M. The stake represents 0.55% of the portfolio and ranks #58 among its holdings.

72 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

Capricorn Fund Managers held 81,879 shares of Cytokinetics worth $6.98M as of Q2 2026.
Cytokinetics was a new Capricorn Fund Managers position in Q2 2026.
Cytokinetics made up 0.55% of Capricorn Fund Managers's portfolio in Q2 2026, its #58 holding.
72 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.